Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Defined daily dose (DDD)
This is a pharmacoeconomic term for the average maintenance dose for the clinical indication of a drug in adult patient.The Defined daily doses (DDDs) are a WHO (The World Health Organization) statistical measure of drug consumption.
A common concern when comparing drugs is that medications can be of different strengths and different potency. However problems can arise when companies attempt to compare 1mg of one medication, with 1mg of another, especially when different countries use different doses. DDD stated aim to solve this by relating all drug use to a standardized unit which is analogous to one day's worth.
Related terms
e-Sampling, General practitioner (GP), Interventions - clinical, Continuing Medical Education (CME), National Institute for Health and Clinical Excellence (NICE), Randomised trial, Eligibility criteria, Concordance, Cohort, Incremental cost-effectiveness ratio (ICER), Healthy years equivalent (HYE), International Clinical Trial Registry Platform (ICTRP), Prescription only medicine (POM), Compliance, Accreditation Council for Continuing Medical Education (ACCME),
Subscribe to our email news alerts
Featured jobs
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Eli Lilly to supply US government with 150,000 additional doses of bebtelovimab
- FDA issues innovative proposal to increase nonprescription drug access
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- NHS App to revolutionise digital health and care with major digital updates by 2023
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- European Commission approves potential new treatment for Pompe disease
- FDA issues innovative proposal to increase nonprescription drug access
- Collaborating to define patient-centred PROs for mutual benefit
- How understanding the rare disease patient’s lived experience creates better health communications
- New medical communications agency BOLDSCIENCE launches
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
